Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Impact of age cutoffs on a lynch syndrome screening program.

Gudgeon JM, Belnap TW, Williams JL, Williams MS.

J Oncol Pract. 2013 Jul;9(4):175-9. doi: 10.1200/JOP.2012.000573. Epub 2012 Nov 13.

PMID:
23942916
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

PMID:
21768580
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.

Schofield L, Goldblatt J, Iacopetta B.

Rural Remote Health. 2011;11(4):1836. Epub 2011 Dec 22.

PMID:
22188021
[PubMed - indexed for MEDLINE]
Free Article
4.

Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.

Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X.

Scand J Gastroenterol. 2011 Nov;46(11):1340-8. doi: 10.3109/00365521.2011.610003. Epub 2011 Aug 31.

PMID:
21879804
[PubMed - indexed for MEDLINE]
5.

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A.

J Clin Oncol. 2008 Dec 10;26(35):5783-8. doi: 10.1200/JCO.2008.17.5950. Epub 2008 Sep 22.

PMID:
18809606
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Lynch syndrome screening implementation: business analysis by a healthcare system.

Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS.

Am J Manag Care. 2011 Aug 1;17(8):e288-300.

PMID:
21851136
[PubMed - indexed for MEDLINE]
Free Article
7.

A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours.

Schofield L, Grieu F, Goldblatt J, Amanuel B, Iacopetta B.

Fam Cancer. 2012 Mar;11(1):1-6. doi: 10.1007/s10689-011-9494-2.

PMID:
22120844
[PubMed - indexed for MEDLINE]
8.

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

Gausachs M, Mur P, Corral J, Pineda M, González S, Benito L, Menéndez M, Espinàs JA, Brunet J, Iniesta MD, Gruber SB, Lázaro C, Blanco I, Capellá G.

Eur J Hum Genet. 2012 Jul;20(7):762-8. doi: 10.1038/ejhg.2011.277. Epub 2012 Jan 25.

PMID:
22274583
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.

van Lier MG, Leenen CH, Wagner A, Ramsoekh D, Dubbink HJ, van den Ouweland AM, Westenend PJ, de Graaf EJ, Wolters LM, Vrijland WW, Kuipers EJ, van Leerdam ME, Steyerberg EW, Dinjens WN; LIMO Study Group.

J Pathol. 2012 Apr;226(5):764-74. doi: 10.1002/path.3963. Epub 2012 Jan 17.

PMID:
22081473
[PubMed - indexed for MEDLINE]
10.

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Mvundura M, Grosse SD, Hampel H, Palomaki GE.

Genet Med. 2010 Feb;12(2):93-104. doi: 10.1097/GIM.0b013e3181cd666c.

PMID:
20084010
[PubMed - indexed for MEDLINE]
11.

Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.

Moline J, Mahdi H, Yang B, Biscotti C, Roma AA, Heald B, Rose PG, Michener C, Eng C.

Gynecol Oncol. 2013 Jul;130(1):121-6. doi: 10.1016/j.ygyno.2013.04.022. Epub 2013 Apr 20.

PMID:
23612316
[PubMed - indexed for MEDLINE]
12.
13.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

PMID:
17764220
[PubMed - indexed for MEDLINE]
Free Article
14.

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.

Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):577-88.

PMID:
11601929
[PubMed - indexed for MEDLINE]
15.

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.

Resnick K, Straughn JM Jr, Backes F, Hampel H, Matthews KS, Cohn DE.

Obstet Gynecol. 2009 Sep;114(3):530-6. doi: 10.1097/AOG.0b013e3181b11ecc.

PMID:
19701031
[PubMed - indexed for MEDLINE]
16.

Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective.

Sie AS, Mensenkamp AR, Adang EM, Ligtenberg MJ, Hoogerbrugge N.

Ann Oncol. 2014 Jul 31. pii: mdu361. [Epub ahead of print]

PMID:
25081898
[PubMed - as supplied by publisher]
17.

Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resection.

Steinhagen E, Shia J, Markowitz AJ, Stadler ZK, Salo-Mullen EE, Zheng J, Lee-Kong SA, Nash GM, Offit K, Guillem JG.

J Am Coll Surg. 2012 Jan;214(1):61-7. doi: 10.1016/j.jamcollsurg.2011.10.004.

PMID:
22192923
[PubMed - indexed for MEDLINE]
18.

Value-based healthcare in Lynch syndrome.

Hennink SD, Hofland N, Gopie JP, van der Kaa C, de Koning K, Nielsen M, Tops C, Morreau H, de Vos tot Nederveen Cappel WH, Langers AM, Hardwick JC, Gaarenstroom KN, Tollenaar RA, Veenendaal RA, Tibben A, Wijnen J, van Heck M, van Asperen C, Roukema AJ, Hommes DW, Hes FJ, Vasen HF.

Fam Cancer. 2013 Jun;12(2):347-54. doi: 10.1007/s10689-013-9655-6.

PMID:
23681793
[PubMed - indexed for MEDLINE]
19.

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.

Sharaf RN, Myer P, Stave CD, Diamond LC, Ladabaum U.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1093-100. doi: 10.1016/j.cgh.2013.04.044. Epub 2013 May 10. Review.

PMID:
23669308
[PubMed - indexed for MEDLINE]
20.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

PMID:
23074514
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk